XML 89 R73.htm IDEA: XBRL DOCUMENT v3.21.2

Fair Value Considerations - Contingent Value Rights (Details) - USD ($) $ in Millions			12 Months Ended
	Mar. 20, 2021	Mar. 31, 2020	Jun. 30, 2021	Jun. 30, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Number of shares issued to contingent value rights share holders		123,820
Contingent value rights amount		$ 2.0
First milestone		$ 24.0
Innovus
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Additional maximum contingent consideration			$ 16.0
Maximum shares to be issued to settle CVR shares			470,000
Number of shares issued to contingent value rights share holders	103,190	123,820
Contingent value rights amount	$ 1.0	$ 2.0
First milestone		$ 24.0
Second milestone	$ 30.0
Milestone not met during the year			$ 1.0
CVR liability			$ 1.4	$ 5.6

X

- Definition

The first revenue milestone for contingent value rights holders of the business acquisition.

+ References

No definition available.

+ Details

Name:	aytu_BusinessCombinationContingentValueRightsFirstRevenueMilestone
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

The maximum amount of contingent value rights of the business combination.

+ References

No definition available.

+ Details

Name:	aytu_BusinessCombinationContingentValueRightsMaximumRangeOfOutcomes
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Contingent value rights revenue milestone not met during the year.

+ References

No definition available.

+ Details

Name:	aytu_BusinessCombinationContingentValueRightsRevenueMilestoneNotMetDuringYear
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

The second revenue milestone for contingent value rights holders of the business acquisition.

+ References

No definition available.

+ Details

Name:	aytu_BusinessCombinationContingentValueRightsSecondRevenueMilestone
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

The maximum number of shares that would be issued to settle the contingent value rights issued in the business acquisition.

+ References

No definition available.

+ Details

Name:	aytu_BusinessCombinationMaximumSharesToBeIssuedToSettleCVR
Namespace Prefix:	aytu_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The fair value portion of contingent value rights.

+ References

No definition available.

+ Details

Name:	aytu_ContingentValueRightsLiabilitiesFairValueDisclosure
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

The number of shares of stock issued during the period to the contingent value rights holders.

+ References

No definition available.

+ Details

Name:	aytu_StockIssuedDuringPeriodSharesContingentValueRights
Namespace Prefix:	aytu_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The value of stock issued during the period for contingent value rights.

+ References

No definition available.

+ Details

Name:	aytu_StockIssuedDuringPeriodValueContingentValueRights
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=aytu_InnovusPharmaceuticalsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: